Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 164 | 1 | 184 | +21 |
| Shares | 93.7M | 141.3K | 94.2M | +610.9K (+0.7%) |
| Value | $1.19B | $1.79M | $747.1M | −$438.8M (−37.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (42)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (21)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Fairmount Funds Management LLC | 3,103,448 | $39.3M |
| TimesSquare Capital Management, LLC | 1,710,926 | $21.7M |
| First Turn Management, LLC | 947,878 | $12.0M |
| Adage Capital Partners GP, L.L.C. | 800,000 | $10.1M |
| Wellington Management Group LLP | 731,303 | $9.27M |
| Frazier Life Sciences Management, L.P. | 689,655 | $8.74M |
| Essex Investment Management Co LLC | 207,574 | $2.63M |
| Samsara BioCapital, LLC | 147,319 | $1.87M |
| Jackson Creek Investment Advisors LLC | 103,592 | $1.31M |
| Legato Capital Management LLC | 62,027 | $785.9K |
| Skandinaviska Enskilda Banken AB (publ) | 41,771 | $525.5K |
| Graham Capital Management, L.P. | 27,950 | $354.1K |
| Virtus ETF Advisers LLC | 27,296 | $345.8K |
| Sherbrooke Park Advisers LLC | 14,865 | $188.3K |
| Vontobel Holding Ltd. | 10,944 | $138.7K |
| TD Asset Management Inc | 10,796 | $136.8K |
| R Squared Ltd | 2,450 | $31.0K |
| Continuum Advisory, LLC | 1,058 | $13.4K |
| Red Tortoise LLC | 216 | $2.74K |
| Spire Wealth Management | 40 | $507 |
| Clearstead Advisors, LLC | 5 | $64 |
Not filed for Q1 2025 yet (1)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 141,298 | $1.79M |